Quadrant Capital »

Palvella Therapeutics Inc Ne shares owned by Quadrant Capital

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0k 10 104.70
2025-09-30 $627 10 62.70

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Schwab Strategic Tr Fundamental Us L (FNDX)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Quadrant Capital

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
State Street Corporation
Perceptive Advisors
Summit Partners Public Asset Management
Jennison Associates
Federated Investors
Woodline Partners
Artisan Partners Limited Partnership
MPM Oncology Impact Management
Caption Management

View all funds holding Palvella Therapeutics Inc Ne